SCHEMBL10013985

SCHEMBL10013985

CN(C)C(=O)COCOCC(=O)N(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.39
SMN1; SMN2 Q16637 3/20 0.38
TSHR P16473 1/20 0.38
KDM4E B2RXH2 4/20 0.34
CYP1A2 P05177 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
HPGD P15428 3/20 0.33
GLA P06280 1/20 0.33
GAA P10253 1/20 0.33
CHRNB2 P17787 2/20 0.32
CHRNA4 P43681 2/20 0.32
CHRNB4 P30926 1/20 0.32
HSD17B10 Q99714 2/20 0.32
TP53 P04637 1/20 0.32
CHRM2 P08172 1/20 0.31
CHRM4 P08173 1/20 0.31
CHRM5 P08912 1/20 0.31
CHRM1 P11229 1/20 0.31
CHRM3 P20309 1/20 0.31
MEN1 O00255 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1258611 0.88 ALDH1A1 (0.42) ALDH1A1SMN1; SMN2TSHRKDM4ECYP1A2
SCHEMBL9845991 0.83 ALDH1A1 (0.39) ALDH1A1SMN1; SMN2TSHRKDM4ECYP1A2
SCHEMBL6229581 0.83
SCHEMBL10402840 0.81
SCHEMBL10402842 0.81
SCHEMBL25332181 0.79 SMN1; SMN2 (0.40) ALDH1A1SMN1; SMN2TSHRKDM4ECYP1A2
SCHEMBL10719258 0.79 ALDH1A1 (0.41) ALDH1A1SMN1; SMN2TSHRKDM4ECYP1A2
SCHEMBL13309281 0.79 CES2 (0.40) ALDH1A1SMN1; SMN2TSHRKDM4ECYP1A2
SCHEMBL9127354 0.79
SCHEMBL4112456 0.77 ALDH1A1 (0.46) ALDH1A1SMN1; SMN2TSHRKDM4ECYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8093352-B2 Polyalkylene oxide polyquaternary ammonium biocides ALCON RESEARCH, LTD. (US) 2012-01-10 US disclosed
US-20100158853-A1 POLYALKYLENE OXIDE POLYQUATERNARY AMMONIUM BIOCIDES ALCON INC. (CH) 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100158853-A1 POLYALKYLENE OXIDE POLYQUATERNARY AMMONIUM BIOCIDES CBR3, QARS1, GLRA3 ALDH1A1 3310/4885SMN1; SMN2 1034/4885TSHR 599/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.